Je selectiemandje is leeg.
Maak een selectie van ETF's die je wilt vergelijken.
Voeg een ETF toe door op "Vergelijk" te klikken op een ETF-profiel of door een ETF aan te vinken in de ETF-zoekfunctie.
TER
0,35% p.a.
Distributiebeleid
Accumulerend
Replicatie
Fysiek
Fondsgrootte
EUR 11 m
Startdatum
2 september 2022
Bedrijven
46
Overzicht
Beschrijving
The VanEck Genomics and Healthcare Innovators UCITS ETF A seeks to track the MVIS Global Future Healthcare ESG index. The MVIS Global Future Healthcare ESG index tracks companies worldwide that are active in the genomics or e-healthcare industries. The stocks included are filtered according to ESG criteria (environmental, social and corporate governance).
Grafiek
Basis
Data
| Index | MVIS Global Future Healthcare ESG |
| Investeringsfocus | Aandelen, Wereld, Gezondheidszorg, Sociaal/Milieu |
| Fondsgrootte | EUR 11 m |
| Totale kostenratio (TER) | 0,35% p.a. |
| Replicatie | Fysiek (Volledige replicatie) |
| Juridische structuur | ETF |
| Strategierisico | Langdurig |
| Duurzaamheid | Yes |
| Valuta van het fonds | USD |
| Valutarisico | Valuta niet gedekt |
| Volatiliteit 1 jaar (in EUR) | 21,14% |
| Startdatum/Noteringsdatum | 2 september 2022 |
| Distributiebeleid | Accumulerend |
| Distributiefrequentie | - |
| Vestigingsplaats van het fonds | Ierland |
| Fondsaanbieder | VanEck |
| Fondsstructuur | Open-ended Investment Company (OEIC) |
| UCITS-conformiteit | Yes |
| Administrateur | State Street Fund Services (Ireland) Limited |
| Beleggingsadviseur | VanEck Asset Management B.V. |
| Bewaarbank | State Street Custodial Services (Ireland) Limited |
| Revisiebedrijf | KPMG Ireland |
| Einde belastingjaar | 31 december |
| Vertegenwoordiger van Zwitserland | Zeidler Regulatory Services (Switzerland) AG |
| Zwitserse uitbetalende instantie | Helvetische Bank AG |
| Duitsland | 30% belastingvermindering |
| Zwitserland | ESTV Reporting |
| Oostenrijk | Belastingrapportagefonds |
| UK | Geen UK-rapportage |
| Indextype | Totale rendementsindex |
| Swap tegenpartij | - |
| Collateral manager | |
| Effectenlening | No |
| Tegenpartij die effecten uitleent |
Vergelijkbare ETF
In dit gedeelte vind je informatie over andere ETF met een vergelijkbare beleggingsfocus als de VanEck Genomics and Healthcare Innovators UCITS ETF A
Vergelijkbare ETF via beleggingsgidsen
Wat vind je van ons ETF-profiel? Here you'll find our Questionnaire.
Bedrijven
Hieronder vind je informatie over de samenstelling van de VanEck Genomics and Healthcare Innovators UCITS ETF A
Top 10 holdings
Weging van top 10-holdings
van 46
61,60%
| Vertex Pharmaceuticals | 9,51% |
| Regeneron Pharmaceuticals, Inc. | 9,16% |
| DexCom | 6,36% |
| Veeva Systems | 5,92% |
| Natera | 5,70% |
| Alnylam Pharmaceuticals | 5,69% |
| Moderna, Inc. | 5,61% |
| Illumina, Inc. | 5,19% |
| Exact Sciences | 4,36% |
| BioNTech SE | 4,10% |
Sectoren
| Gezondheidszorg | 90,41% |
| Consumer Discretionary | 4,11% |
| Essentiële consumptiegoederen | 0,43% |
| Anders | 5,05% |
Vanaf 27/02/2026
Prestaties
Rendementsoverzicht
| YTD | -8,54% |
| 1 maand | -3,77% |
| 3 maanden | -9,21% |
| 6 maanden | -7,22% |
| 1 jaar | +12,74% |
| 3 jaar | -11,57% |
| 5 jaar | - |
| Since inception | -13,94% |
| 2025 | +4,06% |
| 2024 | +0,89% |
| 2023 | -8,09% |
| 2022 | - |
Maandelijks rendement in een heat map
Risico
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risico-overzicht
| Volatiliteit 1 jaar | 21,14% |
| Volatiliteit 3 jaar | 19,71% |
| Volatiliteit 5 jaar | - |
| Rendement/Risico 1 jaar | 0,60 |
| Rendement/Risico 3 jaar | -0,20 |
| Rendement/Risico 5 jaar | - |
| Maximaal waardedaling 1 jaar | -17,57% |
| Maximaal waardedaling 3 jaar | -27,84% |
| Maximaal waardedaling 5 jaar | - |
| Maximaal waardedaling sinds aanvang | -32,60% |
Voortschrijdende volatiliteit over 1 jaar
Beurs
Beursnoteringen
| Beursnotering | Handelsvaluta | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | CURE | - - | - - | - |
| Borsa Italiana | EUR | CURE | - - | - - | - |
| Borsa Italiana | EUR | - | CURE IM CUREUSIV | CURE.MI CUREINAV=SOLA | |
| London Stock Exchange | USD | CURE | CURE LN CUREUSIV | CURE.L CUREUSDINAV=SOLA | |
| London Stock Exchange | GBP | CURG | CURG LN CUREUSIV | CURG.L CUREUSDINAV=SOLA | |
| SIX Swiss Exchange | CHF | CURE | CURE SE CUREUSIV | CURE.S CUREUSDINAV=SOLA | |
| Xetra | EUR | CURE | CURE GY CUREUSIV | CURE.DE CUREINAV=SOLA |
Meer informatie
Nieuwste artikelen
Veelgestelde vragen
What is the name of CURE?
The name of CURE is VanEck Genomics and Healthcare Innovators UCITS ETF A.
What is the ticker of VanEck Genomics and Healthcare Innovators UCITS ETF A?
The primary ticker of VanEck Genomics and Healthcare Innovators UCITS ETF A is CURE.
What is the ISIN of VanEck Genomics and Healthcare Innovators UCITS ETF A?
The ISIN of VanEck Genomics and Healthcare Innovators UCITS ETF A is IE000B9PQW54.
What are the costs of VanEck Genomics and Healthcare Innovators UCITS ETF A?
The total expense ratio (TER) of VanEck Genomics and Healthcare Innovators UCITS ETF A amounts to 0,35% p.a.. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately. Please have a look at our article for more information about the cost of ETFs.
Is VanEck Genomics and Healthcare Innovators UCITS ETF A paying dividends?
VanEck Genomics and Healthcare Innovators UCITS ETF A is an accumulating ETF. This means that dividends are not distributed to investors. Instead, dividends are reinvested in the fund on the ex-date, which leads to an increase of the ETF's share price.
What's the fund size of VanEck Genomics and Healthcare Innovators UCITS ETF A?
The fund size of VanEck Genomics and Healthcare Innovators UCITS ETF A is 11m Euro. See the following article for more information about the size of ETFs.
— Gegevens verstrekt door Trackinsight, etfinfo, Xignite Inc., gettex, FactSet en justETF GmbH.
Standaard zijn ETF-rendementen inclusief dividenduitkeringen (indien van toepassing). Er is geen garantie voor de volledigheid, juistheid en correctheid van de getoonde informatie.